These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8117788)

  • 1. Association of antihypertensive agents and blood lipids in a population-based survey.
    Strickland D; Sprafka JM; Luepker RV; Grimm RH
    Epidemiology; 1994 Jan; 5(1):96-101. PubMed ID: 8117788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is cigarette smoking an effect modifier of the relation between antihypertensive therapy and blood lipids?
    Derby CA; Lapane KL; Hume AL; Babour MM; Carleton RA
    Epidemiology; 1997 Jan; 8(1):48-54. PubMed ID: 9116095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipoprotein levels in treated and untreated hypertensive men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study.
    MacMahon SW; Macdonald GJ; Blacket RB
    Arteriosclerosis; 1985; 5(4):391-6. PubMed ID: 4015511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive treatment and plasma lipoprotein levels. The associations in data from a population study.
    MacMahon SW; Macdonald GJ
    Am J Med; 1986 Feb; 80(2A):40-7. PubMed ID: 3946460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.
    Grimm RH; Flack JM; Grandits GA; Elmer PJ; Neaton JD; Cutler JA; Lewis C; McDonald R; Schoenberger J; Stamler J
    JAMA; 1996 May 22-29; 275(20):1549-56. PubMed ID: 8622245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipids and glucose concentrations in subjects using antihypertensive drugs: Finnmark 1977.
    Arnesen E; Thelle DS; Førde OH; Mjøs OD
    J Epidemiol Community Health; 1983 Jun; 37(2):141-4. PubMed ID: 6886585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive treatment and serum cholesterol: results of population-based surveys in the German Cardiovascular Prevention Study.
    Helmert U; Shea S
    Rev Environ Health; 1997; 12(4):253-60. PubMed ID: 9553999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of antihypertensive treatment patterns and adverse lipid effects in population-based studies.
    Hense HW; Döring A; Stieber J; Keil U
    J Clin Epidemiol; 1992 Dec; 45(12):1423-30. PubMed ID: 1460480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between blood pressure, the treatment of hypertension, and cardiovascular risk factors in women.
    Nanchahal K; Ashton WD; Wood DA
    J Hypertens; 2000 Jul; 18(7):833-41. PubMed ID: 10930179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing cardiovascular disease in hypertension: effects of lowering blood pressure and cholesterol.
    Green R; Kwok S; Durrington PN
    QJM; 2002 Dec; 95(12):821-6. PubMed ID: 12454325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension.
    D'Agostino RB; Kannel WB; Stepanians MN; D'Agostino LC
    Am J Cardiol; 1993 Jan; 71(1):82-7. PubMed ID: 8093585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between blood pressure and serum lipids in a population. The Tromsø Study.
    Bønaa KH; Thelle DS
    Circulation; 1991 Apr; 83(4):1305-14. PubMed ID: 2013148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension, changes in high-density lipoproteins and antihypertensive therapy.
    Flamenbaum W
    Am J Cardiol; 1989 Jun; 63(19):54-57I. PubMed ID: 2658530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antihypertensive treatment on plasma fibrinogen and serum HDL levels in patients with essential hypertension.
    Papadakis JA; Mikhailidis DP; Vrentzos GE; Kalikaki A; Kazakou I; Ganotakis ES
    Clin Appl Thromb Hemost; 2005 Apr; 11(2):139-46. PubMed ID: 15821820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study.
    Wilson PW; Anderson KM; Castelli WP
    Am J Med; 1991 Jan; 90(1):11-6. PubMed ID: 1986576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between arterial hypertension and plasma lipoproteins: the Australian experience].
    MacDonald GJ
    Arch Mal Coeur Vaiss; 1987 Apr; 80 Spec No():29-32. PubMed ID: 2887147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive therapy: taking lipids into consideration.
    Grimm RH
    Am Heart J; 1991 Sep; 122(3 Pt 2):910-8. PubMed ID: 1678922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism.
    Pool JL
    Am Heart J; 1991 Jan; 121(1 Pt 2):251-9; discussion 259-60. PubMed ID: 1824647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined lipid-lowering and antihypertensive treatment as part of a strategy of multiple risk factor intervention.
    Macdonald NJ; Farish E; Stark S; Barnes JF; Rolton H; Saba SN; Elliott HL; Reid JL
    J Hum Hypertens; 1991 Oct; 5(5):449-54. PubMed ID: 1770473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.